Not recruiting
Type 2 diabetes mellitus+4
Not recruitingStudy on the Effects of Alendronate on Bone and Blood Sugar Markers in Patients with Diabetes and Osteopenia/Osteoporosis
Registered drug
Study on the Effects of Alendronate on Bone and Blood Sugar Markers in Patients with Diabetes and Osteopenia/Osteoporosis
Registered drug
- Disease:Type 2 diabetes mellitusType 1 diabetes mellitus+3
- Substances:Alendronate Sodium Monohydrate
Countries:
Denmark
Denmark- Participants:18–64 years · 65+ years
- Substances:Alendronate Sodium Monohydrate
